Subscribe Now Advertise

Categories

search Result

AI simulates trials to predict outcomes and reduce costly methods: Mudit Agarwal

In conversation with Sanskriti Ramachandran, Mudit Agarwal, Founder and CEO, Agrim Tech Services, explains the use of AI in pharma and gives his insights on the pharma industry.Read more

AI can detect anomalies during production: Bharat Shah

In this exclusive interview with Sanskriti Ramachandran, Bharat Shah of SK Healthcare, delves into the role of ai and automation in the pharma industry. Read more

India set to capture 8-10% of CDMO outsourcing by 2033: McKinsey Report

The global CDMO market, currently valued at $224 billion, is forecasted to reach $465 billion by 2032, McKinsey’s analysis revealed.Read more

Effective regulation is the key to fight counterfeiting: Manoj Kochar

In this free-wheeling interview with Rakesh Rao, Manoj Kochar, President, Authentication Solution Providers Association (ASPA), discusses ill-effects of counterfeiting and steps to be taken to combat this menace.Read more

Government funding plays a key role in catalysing AI in pharma

In this interview with Sanskriti Ramachandran, Sudipta Ghosh navigates the role of policies and regulations within the pharma industry.Read more

50 new plants to be established under pharma and medical device PLI scheme

In the first five months of this fiscal year, the pharma and meditech sectors have become the fourth largest manufacturing export sector in India, following automotive, petrochemicals, and electronics. Read more

Aurobindo to acquire remaining 49% stake in GLS Pharma for Rs 225 million

Aurobindo initially acquired a 51% stake in GLS Pharma from promoters Suresh Pathak and his family on June 17, 2022.Read more

Indian pharma sector poised for 8-10% growth this fiscal: CRISIL

Following a successful year with approximately 10% growth, the outlook is bolstered by easing pricing pressures in the US generics market and improved operating leverage, which is expected to raise operating margins by 70-80 basis points to around 22.5%. Read more

Nearly 2,000 drug manufacturing plants overdue for FDA inspections post-COVID

These overdue inspections affect about 42% of the 4,700 registered drug manufacturing plants that were reviewed by the FDA before May 2019.Read more

Over 1,300 units operational under PLI scheme; to generate jobs

Preliminary calculations suggest that the production of Rs 10 trillion under the PLI scheme should translate to incentives worth Rs 500 billion.Read more

Hi There!

Now get regular updates from IPF Magazine on WhatsApp!

Click on link below, message us with a simple hi, and SAVE our number

You will have subscribed to our Industrial News on Whatsapp! Enjoy

+91 84228 74016